Flexible navigable suction ureteral access sheath versus traditional sheath for retrograde kidney stone removal

A Comparative Study Between the Usage of Flexible and Navigable Suction Ureteral Access Sheath (FANS) Versus Traditional Access Sheath in RIRS : Randomized Controlled Trial

Not applicable Interventional Cairo University · NCT07076589

This trial will test whether a flexible, navigable suction ureteral access sheath works better than a traditional sheath for people 14 and older having retrograde intrarenal surgery for kidney or ureteral stones up to 2 cm.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment80 (estimated)
Ages14 Years and up
SexAll
SponsorCairo University Academic / other
Locations1 site (Cairo)
Trial IDNCT07076589 on ClinicalTrials.gov

What this trial studies

This randomized controlled trial compares a flexible, navigable suction ureteral access sheath (FANS) with a traditional ureteral access sheath during retrograde intrarenal surgery (RIRS) for renal and ureteral stones ≤2 cm. Eligible patients are aged 14 and older with non-infected urine, normal renal anatomy, no prior open renal surgery or PCNL on the same side, and no known stone-forming medical conditions. Key outcomes include stone-free rate, clearance of residual fragments, intrarenal pressure–related complications including infection, and need for ancillary interventions. Procedures and follow-up are conducted at Cairo University Hospitals, with participants randomly assigned to FANS or traditional sheath arms.

Who should consider this trial

Good fit: Ideal candidates are people aged 14 or older with a renal or ureteral stone ≤2 cm on CT, non-recurrent disease, non-infected urine, normal urinary anatomy, eGFR ≥60 ml/min, and no known stone-forming medical conditions.

Not a fit: Patients with abnormal urinary tract anatomy, active or uncontrolled urinary infection, eGFR <60 ml/min, metabolic stone-forming disorders, or prior open renal/PCNL on the same side are unlikely to benefit or are excluded.

Why it matters

Potential benefit: If successful, the FANS approach could increase stone-free rates, improve clearance of dust and fragments, reduce intrarenal pressure–related complications, and lower the need for additional procedures.

How similar studies have performed: Similar suction-based and pressure-control adjuncts for RIRS have shown promising results in early or small studies, but randomized head-to-head evidence remains limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥14 years old in patients not known to have stone forming medical conditions.
* Renal stones diameter of ≤2 cm confirmed by CT with all types of configurations (branching \& non-branching).
* Non - recurrent cases with no history of previous open renal surgeries or PCNL with normal renal anatomy.
* Patients with non - infected urine analysis.

Exclusion Criteria:

* Patients with abnormal urinary tract anatomy (such as horseshoe kidney or ileal conduit).
* Patients with medical conditions promoting stone formation (hyperparathyroidism - gout).
* Patients with history of stones on the same side with previous open surgical intervention or PCNL .
* Patients with e-GFR \< 60 ml / min.
* Patients with uncontrolled urinary tract infection.
* Patients with health or other factors that are absolute contraindications to RIRS.
* Patients who are unable to understand or complete trial documentation.

Where this trial is running

Cairo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Stones, KidneyUreter Stones
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.